EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Conditional deletion of the multiple sclerosis susceptibility gene ATXN1 identifies cell‐autonomous effects in the B‐cell compartment

Jonathan Jacob Carver, Rachael Riley Denbrock, Cindy Carolina Martines, Alessandro Didonna iD

The FEBS Journal · 2025

DOI: 10.1111/febs.70328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Jonathan Jacob Carver und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, NC, USA. Hauptthemen laut MEDLINE: Ataxin-1, B-Lymphocytes, Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, East Carolina University, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence supports a mechanistic role for B cells in the pathogenesis of the autoimmune disorder multiple sclerosis (MS). We previously documented that the MS risk gene ataxin‐1 ( ATXN1 ) modulates key B‐cell functions and the severity of the MS disease model experimental autoimmune encephalomyelitis (EAE). ATXN1 encodes the polyglutamine protein ataxin‐1, which works in the cell nucleus as a corepressor of gene transcription. However, considering the ubiquitous expression of the ataxin‐1 protein and the limitations of global Atxn1 ‐null mouse models, the exact contribution of ataxin‐1 to B‐cell functioning and the overall EAE phenotype is not completely understood. To fill this gap, here we employed CRISPR‐mediated genomic editing to develop the first conditional‐knockout mouse line lacking ataxin‐1 in the B‐cell compartment. Using this novel in vivo model, we demonstrated that ataxin‐1 regulates B‐cell proliferation and activation in a cell‐autonomous fashion, and decreases the activation of T cells and monocytes through indirect mechanisms. We also found that depleting ataxin‐1 in B cells affects cytokine and immunoglobulin release in response to encephalitogenic challenges, but it is insufficient to modify the trajectory and neuropathology of the EAE model. Altogether, these results pinpoint a complex regulatory role for ataxin‐1 in autoimmune demyelination involving multiple cellular targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxin-1B-LymphocytesEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsMiceMice, KnockoutLymphocyte ActivationCell ProliferationT-LymphocytesDisease Models, AnimalMice, Inbred C57BLFemaleGene Deletion

Stichwörter der Autor:innen

B cellsataxin‐1autoimmunityexperimental autoimmune encephalomyelitismultiple sclerosis

Substanzen

Ataxin-1Atxn1 protein, mouse

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, NC, USA.

ORCID-Profile: Alessandro Didonna

Förderung

  • NINDS NIH HHS
  • East Carolina University
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Carver, J. J., Denbrock, R. R., Martines, C. C., & Didonna, A. (2025). Conditional deletion of the multiple sclerosis susceptibility gene ATXN1 identifies cell‐autonomous effects in the B‐cell compartment. The FEBS Journal. https://doi.org/10.1111/febs.70328

Vancouver

Carver JJ, Denbrock RR, Martines CC, Didonna A. Conditional deletion of the multiple sclerosis susceptibility gene ATXN1 identifies cell‐autonomous effects in the B‐cell compartment. The FEBS Journal. 2025. doi:10.1111/febs.70328

BibTeX
@article{Carver2025,
  author = {Carver, Jonathan Jacob and Denbrock, Rachael Riley and Martines, Cindy Carolina and Didonna, Alessandro},
  title = {Conditional deletion of the multiple sclerosis susceptibility gene ATXN1 identifies cell‐autonomous effects in the B‐cell compartment},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70328}
}
Kostenlos starten →